You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Title |
Risk-proportionate clinical trial monitoring: an example approach from a non-commercial trials unit
|
---|---|
Published in |
Trials, April 2014
|
DOI | 10.1186/1745-6215-15-127 |
Pubmed ID | |
Authors |
Catrin Tudur Smith, Paula Williamson, Ashley Jones, Alan Smyth, Simon Langton Hewer, Carrol Gamble |
Abstract |
Some level of monitoring is usually required during a clinical trial to protect the rights and safety of trial participants and to safeguard the quality and reliability of trial results. Although there is increasing support for the use of risk-proportionate approaches to achieve these aims, the variety of methods and lack of an empirical evidence base can present challenges for clinical trial practitioners. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 75 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Gambia | 1 | 1% |
Unknown | 74 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 18 | 24% |
Other | 12 | 16% |
Researcher | 12 | 16% |
Student > Postgraduate | 8 | 11% |
Student > Bachelor | 5 | 7% |
Other | 7 | 9% |
Unknown | 13 | 17% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 29 | 39% |
Agricultural and Biological Sciences | 6 | 8% |
Social Sciences | 6 | 8% |
Nursing and Health Professions | 4 | 5% |
Pharmacology, Toxicology and Pharmaceutical Science | 3 | 4% |
Other | 12 | 16% |
Unknown | 15 | 20% |